FLT PET

DRUG2 trials

Sponsors

Columbia University, The Hospital for Sick Children

Conditions

Hodgkin's LymphomaMalignant Melanoma, MetastaticNon-Hodgkin's Lymphoma

Early Phase 1

MRI and PET to Assess Pembrolizumab Response

TerminatedNCT02591654

Columbia UniversityMalignant Melanoma, Metastatic

Start: 2015-10-31End: 2022-10-31Updated: 2022-12-30

Unknown Phase

FLT PET: A Pilot Study in Lymphoma Patients

CompletedNCT04028804

The Hospital for Sick ChildrenHodgkin's Lymphoma, Non-Hodgkin's Lymphoma

Start: 2011-07-31End: 2014-12-31Updated: 2019-07-23